ACES(redirected from Advance Computerized Execution System)
Also found in: Financial.
Azithromycin Coronary Events Study. A trial that asked whether Chlamydia pneumoniae infection is causally associated with cardiovascular disease and, if so, whether azithromycin treatment would reduce the risk of subsequent coronary events.
Randomised, double-blind, placebo-controlled test; adults with stable coronary heart disease. ACES was sponsored by the National Heart, Lung, & Blood Institute; participants randomised to treatment received 600 mg of azithromycin orally once/week X 1 year, then were followed for a mean of 4 years.
Composite—coronary heart disease death, nonfatal myocardial infarction, hospitalisation for unstable angina, coronary revascularisation.
No link between cardiovascular disease and Chlamydia pneumoniae; azithromycin treatment doesn’t affect morbidity or mortality.
Medspeak Abbreviation for:
adverse cardiac event
adverse clinical event
Avelox Clinical Experience Study.
A post-marketing study which assessed the safety and efficacy of Avelox (moxifloxacin), a fluoroquinolone.
Avelox is useful for managing acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial sinusitis, and community-acquired pneumonia.
An acronym for the major dietary antioxidants—vitamin A (and beta carotene), vitamin C, vitamin E, and selenium. Increased consumption of the ACES group is thought to decrease the effects of ageing and stimulate the immune system.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
ACESCardiology A clinical trial–Azithromycin & Coronary Events Study Nutrition An acronyn for the major dietary antioxidants–vitamin A and beta carotene, vitamin C, vitamin E, and selenium
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.